Name of Patient B. V. Age 20 y.

o Height 5’2
Diagnosis G1P1 PU 31 wks. AOG/LMP cephalic, IPTL, severe Sex Female Weight 60 kg
preeclampsia with pulmonary congestion
Author M. M. Olmillo Website milkv.co.vu A/N You’re welcome 

MECHANISM OF ADVERSE
DRUG DATA CLASSIFICATION ACTION
INDICATION CONTRAINDICATION NURSING RESPONSIBILITIES
EFFECTS
Generic name: Pharmacologic: An essential mineral General Hemochromatosis, CNS: seizures, Before:
Multivitamins + Water-soluble found in haemoglobin, indications: hemosiderosis, or other dizziness, > monitor blood studies of patient
FeSO4 vitamins, iron myoglobin, and many Prevention and evidence of iron headaches, > observe proper dosage of medica-

a
supplements enzymes. Enters the treatment of iron- overload; anemias not syncope tion
Trade name/s: bloodstream and is vitamin and due to iron deficiency > note other drugs patient is taking to

vi
Mulvitron transported to the dietary deficiency CV: hypotension, avoid possible interactions
organs of the anemias; used in Precautions: hypertension, > verify the patient’s identity
Patient’s dose: reticuloendothelial anemia due to Use cautiously in peptic tachycardia

d
1 tab OD system (liver, spleen, blood loss during ulcer, ulcerative colitis or During:
Therapeutic: bone marrow), where it menstruation, regional enteritis, GI: nausea, > most effectively absorbed if admin-

e
Minumum dose: Vitamins & minerals, is separated out and infections, alcoholism, severe constipation, dark istered 1 or 2 hrs before meal

ar
125 mg antianemics becomes part of iron surgery, delivery, hepatic impairment, stools, diarrhea, > take with a full glass of water/juice
stores. intoxications, severe renal impairment, vomiting > do not crush/chew enteric-coated
parasitosis, or rheumatoid arthritis, tablets and do not open capsules

sh
Maximum dose: other causes & pregnancy or lactation Dermatologic: > encourage patient to avoid using
750 mg anemias during flushing, urticaria antacids, coffee, tea, dairy products
Pregnancy Category pregnancy Interaction: within 1 hour after

as
Risk: A Drug-drug: antacids that Respiratory: > inform patient about dark, green or
Availability: Onset: 4 days contain calcium. cough, dyspnea black stools to avoid panic
Tablets – 150, tatracylcines,

w
200, 500mg; Peak: 7-10 days biphosphates, H2 MS: arthralgia, After:
capsules – 300, antagonists, proton- myalgia > monitor pt’s blood studies
500mg; syrups – Duration: 2-4 months pump inhibitors > inform patient about what possible

m e
250mg/5mL Patient’s actual Local: pain at IM adverse effects that may occur
Metabolism: mostly indication: Drug-food: iron site > assess bowel function for constipa-

Route: losses co rc
recycled, small daily MV + FeSO4 is
prescribed for
absorption is decreased
33-50% by concurrent Others: staining of
tion/diarrhea
> document and record.
o. ou
PO postpartum administration of food teeth, anaphylaxis,
Distribution: crosses patients to sweating
placenta, enters breast prevent the
er res
milk occurrence of
pregnancy-
Excretion: sweat, induced anemia
urine, bile and keep her
nutritionally
se dy

balanced.
ur tus
H
is
Th

This study source was downloaded by 100000834461673 from CourseHero.com on 10-16-2021 02:56:31 GMT -05:00
 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source: 2011 Source:
Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG Lippincott’s NDG 2011 Lippincott’s Nursing Drug Guide

a
vi
e d
ar
sh
as
w
m e
co rc
o. ou
er res
se dy
ur tus
H
is
Th

This study source was downloaded by 100000834461673 from CourseHero.com on 10-16-2021 02:56:31 GMT -05:00
Powered by TCPDF (www.tcpdf.org)